Last reviewed · How we verify

OFA multimodal analgesia — Competitive Intelligence Brief

OFA multimodal analgesia (OFA multimodal analgesia) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

OFA multimodal analgesia (OFA multimodal analgesia) — Centre Hospitalier Universitaire de Nīmes.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
OFA multimodal analgesia TARGET OFA multimodal analgesia Centre Hospitalier Universitaire de Nīmes marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). OFA multimodal analgesia — Competitive Intelligence Brief. https://druglandscape.com/ci/ofa-multimodal-analgesia. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: